Avadel Pharmaceuticals PLC (AVDL)
18.07
-0.24
(-1.31%)
USD |
NASDAQ |
May 02, 12:14
Avadel Pharmaceuticals Price to Book Value: 18.67 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 18.91 |
| April 30, 2024 | 18.76 |
| April 29, 2024 | 18.56 |
| April 26, 2024 | 18.40 |
| April 25, 2024 | 18.41 |
| April 24, 2024 | 18.24 |
| April 23, 2024 | 18.69 |
| April 22, 2024 | 17.87 |
| April 19, 2024 | 17.90 |
| April 18, 2024 | 17.95 |
| April 17, 2024 | 18.58 |
| April 16, 2024 | 18.69 |
| April 15, 2024 | 17.56 |
| April 12, 2024 | 16.52 |
| April 11, 2024 | 16.49 |
| April 10, 2024 | 16.68 |
| April 09, 2024 | 17.32 |
| April 08, 2024 | 17.69 |
| April 05, 2024 | 17.24 |
| April 04, 2024 | 17.14 |
| April 03, 2024 | 16.83 |
| April 02, 2024 | 16.95 |
| April 01, 2024 | 17.21 |
| March 28, 2024 | 17.45 |
| March 27, 2024 | 17.40 |
| Date | Value |
|---|---|
| March 26, 2024 | 16.78 |
| March 25, 2024 | 17.14 |
| March 22, 2024 | 17.79 |
| March 21, 2024 | 17.65 |
| March 20, 2024 | 17.12 |
| March 19, 2024 | 16.32 |
| March 18, 2024 | 16.29 |
| March 15, 2024 | 16.44 |
| March 14, 2024 | 16.63 |
| March 13, 2024 | 16.61 |
| March 12, 2024 | 16.50 |
| March 11, 2024 | 16.53 |
| March 08, 2024 | 16.89 |
| March 07, 2024 | 16.56 |
| March 06, 2024 | 16.86 |
| March 05, 2024 | 16.33 |
| March 04, 2024 | 16.66 |
| March 01, 2024 | 14.17 |
| February 29, 2024 | 13.20 |
| February 28, 2024 | 12.96 |
| February 27, 2024 | 13.75 |
| February 26, 2024 | 13.42 |
| February 23, 2024 | 12.93 |
| February 22, 2024 | 12.91 |
| February 21, 2024 | 12.99 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.144
Minimum
May 26 2022
18.91
Maximum
May 01 2024
6.805
Average
4.840
Median
Jan 14 2022
Price to Book Value Benchmarks
| Trinity Biotech PLC | -- |
| Medtronic PLC | 2.064 |
| Akari Therapeutics PLC | -- |
| Biophytis SA | -- |
| TC BioPharm (Holdings) PLC | 1.345 |
Price to Book Value Related Metrics
| Price | 18.07 |
| Earnings Yield | -11.12% |
| Market Cap | 1.637B |